Sugistran 12.5mg Capsule (Sunitinib) | Global Oncology Exporter: USA, UK, Thailand, Australia, Singapore, Jamaica | Ernest Impex

Sugistran 12.5mg Capsule (Sunitinib)

Comprehensive Product Profile: What is Sugistran 12.5 mg

Sugistran 12.5mg is a highly specialized oral oncology medication containing the active ingredient Sunitinib. It belongs to a class of drugs known as Multi-Kinase Inhibitors (TKIs). This 12.5mg strength is critical for precise dose titration, allowing oncologists to tailor treatment regimens to the specific needs and tolerance levels of the patient.

Primary Therapeutic Indications

Advanced Renal Cell Carcinoma (RCC): A frontline treatment for advanced or metastatic kidney cancer.

Gastrointestinal Stromal Tumors (GIST): For stomach or bowel tumors that have progressed or for patients who are intolerant to previous therapies.

Pancreatic Neuroendocrine Tumors (pNET): Treats progressive, well-differentiated tumors located in the pancreas.

Adjuvant Treatment: Used to reduce the risk of cancer recurrence in high-risk patients following a nephrectomy (kidney removal).

Mechanism of Action: How Sugistran Works

Sugistran 12.5mg utilizes a “multi-targeted“ pharmacological approach to disrupt the biological infrastructure of the tumor.

Tyrosine Kinase Inhibition: It blocks specific enzymes called Tyrosine Kinases found on the surface of cancer cells. These enzymes act as “switches.“ By locking these switches in the “off“ position, Sugistran prevents the signals that tell cancer cells to multiply and grow.

Anti-Angiogenesis Strategy: It targets Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) receptors. This inhibits the growth of new blood vessels. By cutting off the “nutrient supply lines,“ the tumor is deprived of oxygen and essential nutrients, leading to shrinkage.

Metastasis Suppression: By disrupting vital survival pathways, the medication helps slow or prevent the spread of malignant cells to other parts of the body.

Detailed Clinical Instructions

To ensure maximum therapeutic efficacy and patient safety, follow these administration guidelines:

Dosing Schedule: Sugistran is typically administered in cycles (e.g., 4 weeks of daily treatment followed by a 2-week rest period). Strictly adhere to the specific cycle prescribed by your oncologist.

Administration: Swallow the 12.5mg capsule whole with water. It can be taken with or without food.

Integrity: Never crush, chew, or open the capsule, as this can affect the absorption rate and increase the risk of side effects.

Consistency: Take your dose at the same time every day to maintain a steady concentration of the drug in your bloodstream.

Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels.

Management of Potential Side Effects

As a potent anti-cancer agent, Sugistran 12.5mg may cause adverse reactions. Early identification is key to effective management:

Gastrointestinal: Nausea, diarrhea, vomiting, and “stomatitis“ (mouth sores).

Dermatological: Yellowish skin discoloration (non-jaundice), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles).

Cardiovascular: Hypertension (high blood pressure) is common; regular monitoring is essential.

Endocrine: Changes in thyroid function (Hypothyroidism) or altered taste (dysgeusia).

Hematological: Potential decrease in white blood cell or platelet counts, requiring periodic blood monitoring.

Storage and Handling Protocols

Environmental Control: Store in a cool, dry place away from direct sunlight and humidity.

Temperature Range: Maintain storage at controlled room temperature, ideally between 15°C to 30°C.

Child Safety: Keep strictly out of reach of children and pets.

Waste Management: Do not dispose of unused capsules in household wastewater. Consult your local pharmacist or healthcare provider for proper oncology drug disposal.

Why Choose Ernest Impex?

✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks.

✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, UAE, Australia, Singapore, and Thailand.

✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors.

✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality.

✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation.

We export Impex medicines to:

USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia

📞 Contact Ernest Impex – Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.]

🌐 Websites

www.ernestimpex.com

www.ernestpharmaceuticals.com

www.oncologuymediciensupplier.com

www.ernestvision.com

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

🔗 Direct Chat: https://wa.me/919359902383